Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AB-001 by Agastiya Biotech for Carcinoid Tumor: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Carcinoid Tumor. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Breast Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Breast Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic...
AB-001 by Agastiya Biotech for Colon Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Colon Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Liver Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Liver Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Gastric Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Gallbladder Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Gallbladder Cancer. According to GlobalData, Phase...